Showing results (71-80 of 330) with videos related to

Sort By:
Pageof 33
MDM Policy & Practice|March 6, 2024
Understanding the Impact of Different Modes of Information Provision on Preferences for a Newborn Bloodspot Screening Program in the United KingdomStuart J Wright, Caroline M Vass, Fiona Ulph, et al.
MDM Policy & Practice|January 17, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluationsDon Husereau, Michael Drummond, Federico Augustovski, et al.
MDM Policy & Practice|June 1, 2022
Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic ReviewFatma Maraiki, Shouki Bazarbashi, Paul Scuffham, et al.
MDM Policy & Practice|May 15, 2026
Developing a Novel Values Elicitation Measure for Clinical Use in Older Adults with Hematologic Malignancies: Values-HMDaniel R Richardson, Allison M Deal, Carl J Mhina, et al.
MDM Policy & Practice|May 15, 2026
Development, Testing, and Calibration of LINCS: A New Microsimulation Model of Maternal and Fetal Cytomegalovirus Infection in the United StatesAaron S Wu, Elif Coskun, Malavika Prabhu, et al.
MDM Policy & Practice|July 21, 2020
The Gray Zone: Adolescent and Young Adult Decision Support Needs for Ulcerative ColitisAndrea Meisman, Nancy M Daraiseh, Phil Minar, et al.
MDM Policy & Practice|June 15, 2026
Evaluating the Impact of Different Natural History Modeling Methods on Cost-Effectiveness Decisions: A Case Study in Duchenne Muscular DystrophyJonathan Broomfield, Keith R Abrams, Michael J Crowther, et al.
MDM Policy & Practice|August 28, 2019
Operative Versus Nonoperative Management of Appendicitis: A Long-Term Cost Effectiveness AnalysisLindsay A Sceats, Seul Ku, Alanna Coughran, et al.
MDM Policy & Practice|June 29, 2026
Acceptability of Nonpharmaceutical Interventions to Prevent the Risk of COVID-19 Infection in the United StatesRachel E Murray-Watson, Marcy Ekanayake-Weber, Ted Cohen, et al.
MDM Policy & Practice|June 29, 2026
A Method for Estimating Resource Use and Costs when Empirical Data Are Unavailable: Expert Elicitation Study Using the Example of MelanomaRob Hainsworth, Louisa Collins, Martin Eden, et al.
Pageof 33